Radiologically Guided Biopsies of Metastatic Castration Resistant Prostate Cancer to Identify Adaptive Mechanisms of Resistance

Principal Investigator

Tomasz Beer

Study Purpose

The purpose of this study is to better understand how cancer treatment may affect prostate cancer cells.
The research will involve genetic, molecular, cellular, and immunologic experiments using blood and tumor specimens. It is hoped that the information gained from these studies will lead to a greater understanding of castrate-resistant prostate cancer and potentially, improvements in cancer treatment.

Medical Condition(s)

Metastatic Prostate Cancer that no longer responds to hormone therapy.

Eligibility Criteria

Prostate cancer that has spread outside the prostate and either has recurred after or never responded to hormone therapy.

Age Range

18 - 100

Healthy Volunteers Needed


Duration of Participation

You will have study visits every 3 months until your cancer stops responding to current therapy (about 6 months to 3 years). We will continue to check on you by telephone for the rest of your life.

Minors Included



Clinical trials Information Line: Phone 503-494-1080 or


Stand Up To Cancer-Prostate Cancer Foundation

Recruitment End


Compensation Provided


Go Back